Reduction of interleukin-6, interleukin-8, and anti-phosphatidylserine-prothrombin complex antibody by granulocyte and monocyte adsorption apheresis in a patient with pyoderma gangrenosum and ulcerative colitis.

摘要

To the Editor: Granulocyte and mono-cyte adsorption apheresis (GCAP) is a new extracorporeal apheresis treatment modality that removes pathogenic granulocytes (1-4). We describe the therapeutic effects of GCAP in a patient with pyoderma gan-grenosum and ulcerative colitis.